Hamstring Muscle Strain

2

Review clinical trials related to Hamstring Muscle Strain. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Effectiveness of Dry Needling in Athletes With Chronic Hamstring Strain

This study aims to evaluate the effectiveness of dry needling in reducing pain and improving functional outcomes in athletes with chronic hamstring strain. Chronic hamstring injuries are common among athletes and often lead to persistent pain, reduced performance, and limitations in daily and sports activities. Dry needling is a therapeutic technique used to target myofascial trigger points and relieve muscle tension. This study will compare the effects of dry needling with conventional physiotherapy interventions to determine its role in managing chronic hamstring strain. Participants will be athletes diagnosed with chronic hamstring strain. Outcomes will include pain intensity, muscle flexibility, and functional performance. The results of this study may help improve rehabilitation strategies and provide evidence for the use of dry needling in sports injuries.

Participants needed: 38
Trial details
Age: 18-35Biological sex: MaleType: InterventionalSponsor: Cairo UniversityUpdated: May 6, 2026Locations: 1
Eligibility criteria

Male football players aged 18 to 35 years. [+5]

Previous exposure to dry needling therapy. [+6]

Status: Recruiting

BPC 157 for Acute Hamstring Muscle Strain Repair

This randomized, double-blind, placebo-controlled Phase 2 study evaluates whether pentadecapeptide BPC 157 (BPC-157), an investigational peptide, can speed structural healing and functional recovery after an acute grade II hamstring muscle strain. Participants will receive BPC 157 or placebo for 14 days in addition to a standardized rehabilitation program. The co-primary endpoints are time to return to unrestricted sport and change in MRI-assessed injury volume at Day 14.

Participants needed: 120
Trial details
Phase: Phase 2Age: 18-45Biological sex: AllType: InterventionalSponsor: Hudson BiotechUpdated: Feb 27, 2026Locations: 1
Eligibility criteria

Age 18 to 45 years. [+5]

Grade III hamstring tear, tendon avulsion, or injury requiring surgical manageme... [+9]